Imlunestrant, given alone or in combination with abemaciclib, has demonstrated efficacy in patients with ER+, HER2- advanced breast cancer.
Immediate surgery can improve outcomes among women age 70 and older who are not receiving radiotherapy, data suggest.
This page includes links to articles highlighting the top skin cancer research published on Cancer Therapy Advisor in 2024.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback